WorkforceQA Comments on DOT Drug Testing Changes

WorkforceQA recently submitted comments to the Department of Transportation (DOT) and Office of Drug and Alcohol Policy and Compliance (ODAPC) regarding proposed changes in procedures for transportation workplace drug and alcohol testing programs. In the comments WorkforceQA supported the addition of expanded opiates (hydrocodone, hydromorphone, oxymorphone, and oxycodone) in the DOT drug testing panel, removal of blind specimen testing, and addition of a requirement to subscribe to the DOT ODAPC list-serve resource for collector, screening test technician, breath alcohol technician, substance abuse professional and MRO qualification. Comments were also made regarding changing some verbiage of the proposed regulations.

WorkforceQA’s full submission to DOT and ODAPC may be found at the following link:

NPRM WFQA Comments

 

About WorkforceQA

WorkforceQA is a leading third party administrator of DOT drug and alcohol testing, employee screening and compliance services. Headquartered in Salt Lake City, Utah, the Company provides Medical Review Officer, collection, and third-party administration services to 10,000+ employers across the country. For more information on WorkforceQA, visit www.www.wfqa.com or email info@www.wfqa.com.